134 related articles for article (PubMed ID: 344162)
1. Isoelectric focusing pattern of IgM and surface markers in non-Hodgkin's lymphomas.
Stein H; Bouman H; Lennert K; Fuchs J; Havsteen B
Haematol Blood Transfus; 1977; 20():315-27. PubMed ID: 344162
[No Abstract] [Full Text] [Related]
2. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
Davey FR; Halliday D; Marucci AA; Gottlieb AJ
Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
[No Abstract] [Full Text] [Related]
3. Immunologic markers of non-Hodgkin's lymphomas.
Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
[No Abstract] [Full Text] [Related]
4. Correlation between the presence of surface localized immunoglobulin (Ig) and the histological type of human malignant lymphomas.
Johansson B; Klein E; Haglund S
Clin Immunol Immunopathol; 1976 Jan; 5(1):119-32. PubMed ID: 816584
[No Abstract] [Full Text] [Related]
5. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
6. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
Brubaker DB; Whiteside TL; Hartsock RJ
Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
[TBL] [Abstract][Full Text] [Related]
7. Immunologic surface markers in non-Hodgkin's lymphomas.
Cossman J; Schnitzer B; Deegan MJ
Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
[TBL] [Abstract][Full Text] [Related]
8. Immunologic markers in the differential diagnosis of non-Hodgkin's lymphomas.
Stein H; Staudinger M; Tolksdorf G; Lennert K
J Cancer Res Clin Oncol; 1981; 101(1):29-42. PubMed ID: 7276070
[No Abstract] [Full Text] [Related]
9. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
10. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
[No Abstract] [Full Text] [Related]
11. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
12. Immunologic classification of non-Hodgkin's lymphomas: current status.
Seligmann M; Brouet JC; Preud'homme JL
Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
[No Abstract] [Full Text] [Related]
13. [Information value of isoelectric focusing of serum proteins in non-Hodgkin's lymphomas].
Koĭcheva N; Naĭdenov K; Usheva R
Vutr Boles; 1988; 27(2):71-4. PubMed ID: 3137729
[TBL] [Abstract][Full Text] [Related]
14. Immunofluorometric analyses of membrane bound IgM in individual human lymphoid cells in cases of leukemia and malignant lymphoma.
Killander D; Johansson B; Haglund S
Haematol Blood Transfus; 1977; 20():147-56. PubMed ID: 273002
[No Abstract] [Full Text] [Related]
15. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
16. Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology.
Koziner B; Filippa DA; Mertelsmann R; Gupta S; Clarkson B; Good RA; Siegal FP
Am J Med; 1977 Oct; 63(4):556-67. PubMed ID: 303053
[No Abstract] [Full Text] [Related]
17. Malignant lymphoma of true histiocytic (monocyte/macrophage) origin.
Isaacson P; Wright DH; Jones DB
Cancer; 1983 Jan; 51(1):80-91. PubMed ID: 6336974
[TBL] [Abstract][Full Text] [Related]
18. [Immunodeficiency and lymphomas].
Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
[No Abstract] [Full Text] [Related]
19. [Study of serum immunoglobulins in patients with lymphohistiocytic proliferative disorders].
Sciancalepore G; Casellato MM; Lugaro G ARONEA ; Bosi L; Caprio G
Tumori; 1969; 55(1):27-38. PubMed ID: 4182973
[No Abstract] [Full Text] [Related]
20. Immunologic aspects and pathology of the malignant lymphomas.
Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
